This article is more than 5 years old. Information may no longer be current.
St. Jude Children’s Research Hospital appoints chair of bone marrow transplantation
Click Here to Manage Email Alerts
Stephen Gottschalk, MD, has been appointed chair of the department of bone marrow transplantation and cellular therapy at St. Jude Children’s Research Hospital.
Gottschalk — who will join St. Jude in August — will be responsible for management of the department’s clinical, research and educational activities.
“Bone marrow transplantation and cellular therapy represent some of the most innovative treatments in our fight against cancer and other life-threatening diseases,” James R. Downing, MD, president and CEO of St. Jude, said in a press release. “With Dr. Gottschalk at the department’s helm, St. Jude will expand this program and its efforts in cancer immunotherapy to offer children in Memphis and beyond the best hope for the future.”
Gottschalk has been with the Center of Cell and Gene Therapy and Texas Children’s Cancer Center since 2001. He served as director of Texas Children’s Cancer Center basic and translational research division since 2012. He also has served as professor in the departments of pediatrics and immunology at Baylor College of Medicine.
“Cell-based immunotherapies hold the promise to improve outcomes for children with cancer who currently cannot be cured,” Gottschalk said in the release. “Because cell therapies are also highly cancer specific, they might ultimately reduce the incidence of long-term, treatment-related complications endured by all cancer survivors. St. Jude is in a unique position to build a highly innovative pediatric cell therapy program. I am honored and delighted to lead this effort.”